Abstract PD4-06: First-line ribociclib + letrozole in hormone receptor-positive, HER2-negative advanced breast cancer: Efficacy by baseline circulating tumor DNA alterations in MON... von Hortobagyi, GN, Stemmer, S, Campone, M, Sonke, GS, Arteaga, CL, Paluch-Shimon, S, Petrakova, K, Villanueva, C, Nusch, A, Grischke, E-M, Chan, A, Jakobsen, E, Marschner, N, Hart, LL, Alba, E, Ohnstand, HO, Blau, S, Yardley, DA, Solovieff, N, Su, F, Germa, C, Yap, Y-S

Volltext